Why Biosimilars are Malaysia's next health investment – NST Online

Why Biosimilars are Malaysia’s next health investment  NST OnlineEU Clears Path for Biosimilars in Diabetes & Bone Health  MedscapeCHMP Positive Opinions for Denosumab & Insulin Glargine Biosims  Pearce IPEMA recommends approval for nine biosimilars  Generics and Biosimilars InitiativeBiosimilars: a vital remedy for Europe’s healthcare challenges  Labiotech.eu